Atlas Trials

Fondazione Italiana Sindromi Mielodisplastiche-ETS

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Fondazione Italiana Sindromi Mielodisplastiche-ETS

RecordFirmDate
Efficacy and Safety of Luspatercept: a Study by Fondazione Italiana Sindromi Mielodisplastiche (NCT05520749)Fondazione Italiana Sindromi Mielodisplastiche-ETS2022-01-01
Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care (NCT04212390)Fondazione Italiana Sindromi Mielodisplastiche-ETS2020-06-03
Early and Low Dose Deferasirox (3.5 mg/kg FCT) to Suppress NTBI and LPI as Early Intervention to Prevent Tissue Iron Overload in Lower Risk MDS (NCT03920657)Fondazione Italiana Sindromi Mielodisplastiche-ETS2019-10-04
Italian Network MDS Registry (NCT02808858)Fondazione Italiana Sindromi Mielodisplastiche-ETS2013-09-01
Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy (NCT01956799)Fondazione Italiana Sindromi Mielodisplastiche-ETS2013-05-01
Multicenter Study to Assess the Efficacy of Decitabine in the Treatment of Chronic Myelomonocytic Leukemia (NCT01251627)Fondazione Italiana Sindromi Mielodisplastiche-ETS2010-04-01
Multicentric Study Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy With Acid 13-cis-retinoic and Dihydroxyvitamin D3 in Myelodysplastic Syndromes Without Excess of Blasts (NCT00804050)Fondazione Italiana Sindromi Mielodisplastiche-ETS2007-03-01
Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes (NCT00803530)Fondazione Italiana Sindromi Mielodisplastiche-ETS2005-09-01
Study of Clofarabine in Combination With Low Dose Cytarabine to Treat Myelodysplastic Syndromes (NCT01302106)Fondazione Italiana Sindromi Mielodisplastiche-ETS

Track Fondazione Italiana Sindromi Mielodisplastiche-ETS automatically

Every clearance here is in the API, with alerts when new ones post.